AIONX ANTIMICROBIAL TECHNOLOGIES, INC.

Profile

Company Names

AIONX ANTIMICROBIAL TECHNOLOGIES, INC.
ARGENTUMCIDALELECTRICS, INC.

Addresses

515 REAR WEST CHOCOLATE AVENUE, HERSHEY, PA 17033

12701 FERGUSON VALLEY ROAD, LEWISTOWN, PA 17044

Phone Numbers

888-512-4669
717-248-9919

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER TECHNOLOGY

Year Incorporated:

2006

State Incorporated:

PENNSYLVANIA

Total Amount Raised:

$6,321,794.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2022-06-08 
$101,157.00 
$2,500,002.00 
$2,398,845.00 
Equity 
5
2019-12-31 
$1,130,000.00 
$1,500,000.00 
$370,000.00 
Debt 
4
2016-08-10 
$3,845,545.00 
$7,000,161.00 
$3,154,616.00 
Equity 
3
2013-01-14 
$494,908.00 
$750,000.00 
$255,092.00 
Equity 
2
2011-06-01 
$500,184.00 
$500,184.00 
$0.00 
Equity 
1
2010-02-22 
$250,000.00 
$250,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GREGORY 
BAILEY 
DIRECTOR
GREGORY 
M. 
BAILEY 
DIRECTOR
PAUL 
COHEN 
DIRECTOR
PAUL 
H. 
COHEN 
DIRECTOR
THOMAS 
FULLER 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
THOMAS 
A. 
FULLER 
EXECUTIVE OFFICER, PROMOTER, DIRECTOR
TERRY 
MARGOLIS 
DIRECTOR
TERRY 
J. 
MARGOLIS 
DIRECTOR
RYAN 
J. 
MCCOMBIE 
DIRECTOR
WAYNE 
SEBASTIANELLI 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
WAYNE 
J. 
SEBASTIANELLI 
DIRECTOR
GARY 
J. 
SHOPE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ROBERT 
VOIGT 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
C. 
VOIGT 
DIRECTOR
RICHARD 
WYSK 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
RICHARD 
A. 
WYSK 
DIRECTOR
JON 
ZIMMERMAN 
EXECUTIVE OFFICER, DIRECTOR
JON 
C. 
ZIMMERMAN 
EXECUTIVE OFFICER, DIRECTOR
SETH 
 
ZIMMERMAN 
EXECUTIVE OFFICER
SETH 
R. 
ZIMMERMAN 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-08 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2019-12-31 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2019-12-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-12-31 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2016-08-10 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity, Debt 
2016-08-10 
D
OTHER TECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-01-14 
D
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2011-06-01 
D
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2010-02-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#